Search for: "Janssen Pharmaceuticals Inc." Results 61 - 80 of 244
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Mar 2016, 8:00 am by Robert Kreisman
The federal district court has entered a ruling that Janssen Pharmaceuticals Inc. should pay penalties for violating South Carolina law. [read post]
29 Feb 2016, 11:27 pm
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive… [read post]
24 Feb 2016, 5:14 am
Janssen Pharmaceuticals, Inc., 2016 WL 633673 (E.D. [read post]
23 Feb 2016, 1:53 am
Mark has some ideas about that.* Of Mice and Men: Regeneron v KymabAs David's post on Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor [2016] EWHC 87 (Pat) clearly shows, mice have a very special relation with patent case law. [read post]
18 Jan 2016, 5:00 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F.3d 281 (6th Cir. 2015) – preemption, but not involving generic drugs − which aptly described pre-approval theories as “never-start selling” claims (id. at 300), describes that other decision. [read post]
11 Jan 2016, 7:32 am by Associated Press
The justices on Monday let stand a lower court ruling that said Janssen Pharmaceuticals, Inc. should pay the penalties for violations of South Carolina law. [read post]
4 Jan 2016, 7:49 am by Law Offices of Jeffrey S. Glassman
Ortho-McNeil-Janssen Pharma., Inc: Defective Drug Lawsuits appeared first on Product Liability Lawyer Blog. [read post]
17 Dec 2015, 5:50 pm by Sean Wajert
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
17 Dec 2015, 5:50 pm by Sean Wajert
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
17 Dec 2015, 5:50 pm by Sean Wajert
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
10 Dec 2015, 8:00 pm by John Ehrett
The petition of the day is: Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
17 Nov 2015, 5:07 am by Grimes Teich Anderson LLP
Recent articles in Forbes Magazine and The Wall Street Journal reported that Janssen Pharmaceuticals, Inc., which is a Johnson & Johnson company, has been accused of a failure to warn about the side effect. [read post]
10 Nov 2015, 11:33 am by Tom Lamb
"] The findings are contrary to data presented [in "New Global Real-World Data from Atrial Fibrillation Studies Confirm the Safety Profile of XARELTO®", a press release from Janssen Pharmaceuticals, Inc.] on the safety of [Xarelto (rivaroxaban)] in 39,052 people with NVAF showed the rates and patterns of major bleeding in routine clinical practice were 2.89 per 100 person-years. [read post]
9 Nov 2015, 7:39 am
Merck Sharp & Dohme v Ono Pharmaceutical [2015] EWHC 2973 (Pat), decided on 22 October by Mr Justice Birss in the Patents Court, England and Wales, is a decidedly unbifurcated ruling, being a full-blooded infringement-and-invalidity action running to 243 paragraphs. [read post]